EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus

Teressa S Thomas, Carolyn Dunderdale, Michael T Lu, Allie R Walpert, Grace Shen, Michele C H Young, Martin Torriani, Jacqueline T Chu, Hanna H Haptu, Monica Manandhar, Alysse Wurcel iD, Gail K Adler iD und 2 weitere

Open Forum Infectious Diseases · 01.08.2023 · 10 (8)

DOI: 10.1093/ofid/ofad398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.07.2023. Verfasst von Teressa S Thomas und 13 weiteren Autor:innen. Beteiligte Einrichtung: Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persons with well-treated human immunodeficiency virus (HIV) demonstrate a 2-fold higher risk of cardiovascular disease (CVD), which may be related to excess visceral adipose tissue (VAT). The visceral adiposity index (VAI) is a score to approximate VAT by combining biochemical measures with anthropometrics without quantification by imaging. We evaluated VAI in association with cardiometabolic factors among persons with HIV (PWH).

Methods

Forty-five PWH on antiretroviral therapy and virologically controlled with increased abdominal VAT (VAT area >110 cm2 on CT) and no known CVD were included. VAI was calculated using standard sex-specific formulas. Coronary plaque was assessed using coronary CT angiography.

Results

Participants were predominantly male (73%), white (53%), and non-Hispanic (84%), with a mean age of 55 (standard deviation, 7) years. Among PWH, median VAI was calculated to be 4.9 (interquartile range [IQR], 2.8–7.3). Log VAI correlated with log VAT (r = 0.59, P < .0001) and anthropometric measures (body mass index: r = 0.36, P = .02; waist circumference: r = 0.43, P = .004; waist-to-hip ratio: r = 0.33, P = .03). Participants with coronary plaque had a higher VAI compared to those without coronary plaque (median, 5.3 [IQR, 3.4–10.5] vs 2.8 [IQR, 1.8–5.0]; P = .004). VAI (area under the curve = 0.760, P = .008) performed better than the atherosclerotic CVD risk score to predict the presence of plaque in receiver operating characteristic analyses.

Conclusions

VAI may be a useful biomarker of metabolic dysfunction and increased CVD risk that may occur with VAT accumulation in PWH. Clinical Trials Registration NCT02740179.

Schlagwörter

Stichwörter der Autor:innen

HIVcardiovascular diseasecoronary plaquevisceral adipose tissuevisceral adiposity index

Autor:innen und Institutionen

  • Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Mass General Brigham and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Alysse Wurcel, Gail K Adler, Suman Srinivasa

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Thomas, T. S., Dunderdale, C., Lu, M. T., Walpert, A. R., Shen, G., Young, M. C. H., Torriani, M., Chu, J. T., Haptu, H. H., Manandhar, M., Wurcel, A., Adler, G. K., Grinspoon, S. K., & Srinivasa, S. (2023). Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 10(8). https://doi.org/10.1093/ofid/ofad398

Vancouver

Thomas TS, Dunderdale C, Lu MT, Walpert AR, Shen G, Young MCH, et al. Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 2023;10(8). doi:10.1093/ofid/ofad398

BibTeX
@article{Thomas2023,
  author = {Thomas, Teressa S and Dunderdale, Carolyn and Lu, Michael T and Walpert, Allie R and Shen, Grace and Young, Michele C H and Torriani, Martin and Chu, Jacqueline T and Haptu, Hanna H and Manandhar, Monica and Wurcel, Alysse and Adler, Gail K and Grinspoon, Steven K and Srinivasa, Suman},
  title = {Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus},
  journal = {Open Forum Infectious Diseases},
  year = {2023},
  volume = {10},
  number = {8},
  doi = {10.1093/ofid/ofad398}
}
Kostenlos starten →